Displaying One Session

Collaborative session

Optimising development and uptake of precision oncology in the Far East (In collaboration with National Societies)

Academic research contributions in oncology drug development (ID 1306)

Session Name
Optimising development and uptake of precision oncology in the Far East (In collaboration with National Societies)
Speakers
  • Ruihua Xu (Guangzhou, Guangdong, China)
Duration
15 Minutes

The development and implementation of biosimilars in the era of personalized cancer medicine (ID 1307)

Session Name
Optimising development and uptake of precision oncology in the Far East (In collaboration with National Societies)
Speakers
  • Dennis L. Sacdalan (Manila, Ermita, Philippines)
Duration
15 Minutes

Pharmacogenetics in the practice of molecular oncology: Value or luxury? (ID 1308)

Session Name
Optimising development and uptake of precision oncology in the Far East (In collaboration with National Societies)
Speakers
  • Naiyarat Prasongsook (Bangkok, Bangkok, Thailand)
Duration
15 Minutes

The value of RWE for assessing safety and effectiveness of targeted agents in cancer (ID 1309)

Session Name
Optimising development and uptake of precision oncology in the Far East (In collaboration with National Societies)
Speakers
  • Miriam Koopman (Utrecht, Netherlands)
Duration
15 Minutes